Answers are grounded in this paper and cite their sources.
Background A body of type 2 diabetes mellitus (T2DM)-related cardiovascular and kidney research accumulated before the introduction of the cardiovascular–kidney–metabolic (CKM) health framework. Previous bibliometric studies have focused on traditional cardiorenal topics or recent literature explicitly using CKM-related terminology, leaving the long-term knowledge structure of T2DM-related cardiorenal research and its development toward CKM research insufficiently characterized. This study aimed to map knowledge evolution, examine links between earlier cardiorenal evidence and recent CKM research, and identify emerging research directions. Methods We searched Web of Science Core Collection and Scopus for English-language articles and reviews published from 2000 to 1 June 2026, constructing dataset 1 (D1; T2DM-related cardiorenal research) and dataset 2 (D2; T2DM research using CKM-related terminology). VOSviewer, CiteSpace, and bibliometrix were used to analyze publication trends, collaboration networks, intellectual foundations, thematic structures, and temporal evolution, alongside overlap and thematic links between datasets. Results D1 and D2 included 2,538 and 305 publications, respectively, with 202 shared publications (66.2% of D2). The proportion of annual D1 publications shared with D2 increased from 5.1% in 2023 to 19.9% in 2025. Co-citation and thematic evolution analyses traced an expansion from kidney risk control to multiorgan outcomes. Early research addressed diabetic nephropathy, albuminuria, renin–angiotensin system blockade, and comprehensive risk factor control, alongside cardiovascular outcomes. Research attention subsequently broadened toward cardiorenal outcomes, including chronic kidney disease and heart failure outcomes, as well as multiorgan risk and organ-protective therapies. The D2 analysis identified an interconnected thematic structure encompassing chronic kidney disease, heart failure, obesity, cardiovascular risk, and organ-protective therapies. Keyword bursts for CKM syndrome, glucagon-like peptide-1 receptor agonists, body composition, and gut microbiota remained active at the search cutoff, suggesting growing interest in metabolic risk phenotypes and potential mechanisms. Conclusion The mapped literature showed a broadening of research attention from kidney risk control toward multiorgan outcomes and integrated management, with publication overlap and thematic links between the two retrieved corpora. The dual-dataset design situates emerging CKM frontiers within the historical development of T2DM-related cardiorenal research literature, providing a systematic bibliometric basis for multiorgan risk research and interdisciplinary research agendas from a CKM perspective.
No takes yet. Share an insight, caveat, or question.
Cong et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: